相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Myung Jong Kim et al.
HUMAN MOLECULAR GENETICS (2018)
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
S. Pablo Sardi et al.
MOVEMENT DISORDERS (2018)
Alpha galactosidase A activity in Parkinson's disease
R. N. Alcalay et al.
NEUROBIOLOGY OF DISEASE (2018)
Analysis of age-related changes in psychosine metabolism in the human brain
Michael S. Marshall et al.
PLOS ONE (2018)
LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease
Maria Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Axonal dystrophy in the brain of mice with Sanfilippo syndrome
Helen Beard et al.
EXPERIMENTAL NEUROLOGY (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Genetic effects on gene expression across human tissues
Francois Aguet et al.
NATURE (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
A dose effect of mutations in the GBA gene on Parkinson's disease phenotype
Avner Thaler et al.
PARKINSONISM & RELATED DISORDERS (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity
Daniel Ysselstein et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type
Elisabet Ihse et al.
SCIENTIFIC REPORTS (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
SMPD1 Mutation Update: Database and Comprehensive Analysis of Published and Novel Variants
Stefania Zampieri et al.
HUMAN MUTATION (2016)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases
Maria J. Ferraz et al.
FEBS LETTERS (2016)
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2016)
Krabbe Disease: One Hundred Years From the Bedside to the Bench to the Bedside
David A. Wenger et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Finding common ground PERSPECTIVE Finding common ground
Anthony H. Futerman et al.
NATURE (2016)
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models
Joseph R. Mazzulli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Crystal structure of mammalian acid sphingomyelinase
Alexei Gorelik et al.
NATURE COMMUNICATIONS (2016)
Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry
Gregory A. Grabowski et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies
Davide Chiasserini et al.
MOLECULAR NEURODEGENERATION (2015)
The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms
Jin-Sung Park et al.
MOVEMENT DISORDERS (2015)
Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity
Daniel Ysselstein et al.
NEUROBIOLOGY OF DISEASE (2015)
The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews
E. Dagan et al.
PARKINSONISM & RELATED DISORDERS (2015)
The emerging role of SMPDI mutations in Parkinson's disease: Implications for future studies
Ziv Gan-Or et al.
PARKINSONISM & RELATED DISORDERS (2015)
New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson Disease
Sonia Lehri-Boufala et al.
PLOS ONE (2015)
Progressive decline of glucocerebrosidase in aging and Parkinson's disease
Emily M. Rocha et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy
Constanza J. Cortes et al.
DRUG DISCOVERY TODAY (2014)
Zn2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation
Taiji Tsunemi et al.
HUMAN MOLECULAR GENETICS (2014)
ATP13A2/PARK9 Regulates Secretion of Exosomes and α-Synuclein
Taiji Tsunemi et al.
JOURNAL OF NEUROSCIENCE (2014)
Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease
Benjamin R. Smith et al.
JOURNAL OF PATHOLOGY (2014)
Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients
Wei-Lien Chuang et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance
Michelle Rothaug et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mutations in the ATP13A2 Gene and Parkinsonism: A Preliminary Review
Xinglong Yang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
THE NEURONAL CEROID-LIPOFUSCINOSES
Michael J. Bennett et al.
DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2013)
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited -synuclein accumulation and age-dependent sensorimotor deficits
Patrick J. Schultheis et al.
HUMAN MOLECULAR GENETICS (2013)
The Sphingolipid Psychosine Inhibits Fast Axonal Transport in Krabbe Disease by Activation of GSK3β and Deregulation of Molecular Motors
Ludovico Cantuti Castelvetri et al.
JOURNAL OF NEUROSCIENCE (2013)
Parkinsonism syndrome in heterozygotes for Niemann-Pick C1
Hans H. Kluenemann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease
Jia-Nee Foo et al.
NEUROBIOLOGY OF AGING (2013)
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
Ziv Gan-Or et al.
NEUROLOGY (2013)
Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease
Huiwen Zhang et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Autophagic/lysosomal dysfunction in Alzheimer's disease
Miranda E. Orr et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1
Rao Fu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2
Nathan Pankratz et al.
ANNALS OF NEUROLOGY (2012)
Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis
Jose Bras et al.
HUMAN MOLECULAR GENETICS (2012)
Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide
Serene Keilani et al.
JOURNAL OF NEUROSCIENCE (2012)
Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, α-Synuclein Accumulation, and Neurotoxicity
Marija Usenovic et al.
JOURNAL OF NEUROSCIENCE (2012)
Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome
Sophie E. Winder-Rhodes et al.
MOVEMENT DISORDERS (2012)
ATP13A2 Variability in Taiwanese Parkinson's Disease
Chiung-Mei Chen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2011)
Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation
A. Fiumara et al.
CLINICAL GENETICS (2011)
Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2011)
A Mutation in SCARB2 is a Modifier in Gaucher Disease
Arash Velayati et al.
HUMAN MUTATION (2011)
Regulation of Intracellular Manganese Homeostasis by Kufor-Rakeb Syndrome-associated ATP13A2 Protein
Jieqiong Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
Y. H. Xu et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Lysosomal Storage Disorders and Parkinson's Disease: Gaucher Disease and Beyond
Tamar Shachar et al.
MOVEMENT DISORDERS (2011)
A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers
Fabiana H. G. Farias et al.
NEUROBIOLOGY OF DISEASE (2011)
Mucopolysaccharidosis Type IIIA: Clinical Spectrum and Genotype-Phenotype Correlations
Marlies J. Valstar et al.
ANNALS OF NEUROLOGY (2010)
Acid sphingomyelinase, cell membranes and human disease: Lessons from Niemann-Pick disease
Edward H. Schuchman
FEBS LETTERS (2010)
Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting
Anna M. Vaccaro et al.
HUMAN MOLECULAR GENETICS (2010)
Identification and Characterization of 15 Novel GALC Gene Mutations Causing Krabbe Disease
Barbara Tappino et al.
HUMAN MUTATION (2010)
The risk of Parkinson's disease in type 1 Gaucher disease
Gilberto Bultron et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype
C. C. S. Delnooz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
Wing C. Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
Gaucher Disease Ascertained Through a Parkinson's Center: Imaging and Clinical Characterization
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology
Thomas Kirkegaard et al.
NATURE (2010)
Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China
Qing-Zhou Fei et al.
NEUROSCIENCE LETTERS (2010)
Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells
Barbara Karten et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol
Hyock Joo Kwon et al.
CELL (2009)
Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A
Barbara Buccinna et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Genetic Association Study of the P-Type ATPase ATP13A2 in Late-Onset Parkinson's Disease
Aleksandar Rakovic et al.
MOVEMENT DISORDERS (2009)
ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls
Ana Djarmati et al.
MOVEMENT DISORDERS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
ACOG Committee Opinion No. 442: Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent
OBSTETRICS AND GYNECOLOGY (2009)
NPC-db, a Niemann-Pick type C disease gene variation database
Heiko Runz et al.
HUMAN MUTATION (2008)
Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Kathleen S. Hruska et al.
HUMAN MUTATION (2008)
Sanfilippo syndrome: A mini-review
M. J. Valstar et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase
Cristian Galvan et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
Emyr Lloyd-Evans et al.
NATURE MEDICINE (2008)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore
C. H. Lin et al.
NEUROLOGY (2008)
Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue
Kimiko Hamano et al.
ACTA NEUROPATHOLOGICA (2008)
Neuronal and glial accumulation of α- and β-synucleins in human lipidoses
Kyoko Suzuki et al.
ACTA NEUROPATHOLOGICA (2007)
The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease
E. H. Schuchman
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
A. Di Fonzo et al.
NEUROLOGY (2007)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis
Paige Kaplan et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2006)
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
I Ron et al.
HUMAN MOLECULAR GENETICS (2005)
Sanfilippo type B syndrome:: five patients with an R565P homozygous mutation in the α-N-acetylglucosaminidase gene from the Okinawa islands in Japan
Y Chinen et al.
JOURNAL OF HUMAN GENETICS (2005)
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study
H Pavlu-Pereira et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Aberrant phosphorylation of α-synuclein in human Niemann-Pick type C1 disease
Y Saito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
Glucocerebrosidase mutations in subjects with parkinsonism
A Lwin et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport
DT Vruchte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Juvenile Sandhoff disease - Nine new cases and a review of the literature
CJ Hendriksz et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Perinatal-lethal Gaucher disease
C Mignot et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Neuronal accumulation of α- and β-synucleins in the brain of a GM2 gangliosidosis mouse model
K Suzuki et al.
NEUROREPORT (2003)
Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro
JA Cohlberg et al.
BIOCHEMISTRY (2002)
Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease
K Harzer et al.
CLINICA CHIMICA ACTA (2002)
Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations
M Zervas et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Mucopolysaccharidosis type IIIB:: characterisation and expression of wild-type and mutant recombinant α-N-acetylglucosaminidase and relationship with Sanfilippo phenotype in an attenuated patient
G Yogalingam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Krabbe disease: Genetic aspects and progress toward therapy
DA Wenger et al.
MOLECULAR GENETICS AND METABOLISM (2000)
分享论文
